ORIGINAL ARTICLE |
|
Year : 2016 | Volume
: 28
| Issue : 3 | Page : 99-107 |
|
Serum chemerin level in chronic kidney disease
Samiha Abo Eiyazeed Abd Rabo1, Nagwa Abdel Ghaffar Mohamed2, Naglaa Abd Elfattah Tawfik PhD 1, Marwa Mosa Hamed3
1 Department of Internal Medicine, Faculty of Medicine for Girls, Al Azhar University, Cairo, Egypt 2 Department of Clinical and Chemical Pathology, National Research Center, Cairo, Egypt 3 Department of Internal Medicine, General Helwan Hospital, Cairo, Egypt
Correspondence Address:
Naglaa Abd Elfattah Tawfik Faculty of Medicine, Assiut University, Assiut Egypt
Source of Support: None, Conflict of Interest: None | Check |
DOI: 10.4103/1110-7782.200964
|
|
Background
Chronic kidney disease (CKD) is a progressive loss in renal function over a period of months or years. In the metabolic association of an elevated circulating chemerin level in the context of uremia demonstrate that high chemerin levels predict a better survival in CKD patients. The aim of the study was to measure serum chemerin and to correlate it with other parameters in CKD patients.
Patients and methods
This study was conducted on 40 patients with CKD, including 20 patients with end-stage renal disease under regular hemodialysis and 20 patients with renal impairment on conservative therapy who have not started hemodialysis, and 22 apparently healthy participants serving as the control group. Human chemerin is determined by sandwich enzyme immunoassay.
Results
There is a highly statistically significant difference in mean serum chemerin and mean serum high-sensitivity C-reactive protein (hs-CRP) in the patient groups in comparison with the control group. In addition, there was a highly statistically significant difference between control group, under hemodialysis group, and renal impairment group as regards serum chemerin and serum hs-CRP. A positive correlation between serum chemerin and hs-CRP studied in the under hemodialysis group, renal impairment group, and in all patients’ group.
Conclusion
A significantly higher chemerin level in patients with impaired kidney function compared with the normal control group, and a high increase in patients under hemodialysis compared with the other two groups. |
|
|
|
[FULL TEXT] [PDF]* |
|
|
|